1. Home
  2. STXS

as of 11-28-2025 12:39pm EST

$2.43
$0.01
-0.21%
Stocks Health Care Biotechnology: Electromedical & Electrotherapeutic Apparatus Nasdaq

Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems; Disposables, Royalty; and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.

Chart Type:
Time Range:
Founded: 1990 Country:
United States
United States
Employees: N/A City: ST.LOUIS
Market Cap: 244.1M IPO Year: 2004
Target Price: $4.00 AVG Volume (30 days): 695.3K
Analyst Decision: Strong Buy Number of Analysts: 1
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -0.28 EPS Growth: N/A
52 Week Low/High: $1.54 - $3.59 Next Earning Date: 11-11-2025
Revenue: $30,075,000 Revenue Growth: 19.62%
Revenue Growth (this year): 30.98% Revenue Growth (next year): 49.86%

AI-Powered STXS Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated 2 days ago

AI Recommendation

hold
Model Accuracy: 61.63%
61.63%
Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

Stock Insider Trading Activity of Stereotaxis Inc. (STXS)

Isaac Paul J

Director, Other

Buy
STXS Nov 17, 2025

Avg Cost/Share

$2.18

Shares

10,000

Total Value

$21,800.00

Owned After

97,299

SEC Form 4

Isaac Paul J

Director, Other

Buy
STXS Nov 14, 2025

Avg Cost/Share

$2.24

Shares

20,000

Total Value

$44,800.00

Owned After

97,299

SEC Form 4

Latest Stereotaxis Inc. News

STXS Breaking Stock News: Dive into STXS Ticker-Specific Updates for Smart Investing

All STXS News

Share on Social Networks: